Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MPT0B002 is a microtubule inhibitor that acts by downregulating T315I mutant Bcr-Abl and inducing apoptosis of imatinib-resistant chronic myeloid leukemia cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | MPT0B002 is a microtubule inhibitor that acts by downregulating T315I mutant Bcr-Abl and inducing apoptosis of imatinib-resistant chronic myeloid leukemia cells. |
Synonyms | MPT-0-B-002, MPT 0 B 002 |
Molecular Weight | 325.36 |
Formula | C19H19NO4 |
CAS No. | 946077-08-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MPT0B002 946077-08-3 MPT 0 B002 MPT-0-B-002 MPT 0 B 002 MPT0B 002 MPT-0-B 002 MPT0B-002 MPT-0-B002 MPT 0 B-002 MPT-0B002 inhibitor inhibit